Metformin mediates the PMN-MDSCs reduction in the tumor via activation of AMPK, which upregulates dachshund homolog 1 (DACH1) expression on tumor cells and, therefore, downregulates CXCL1 expression [65]. Here, DACH1 is linked to neoplasm.